Delving into the Intricacies of Preclinical Development of Inflammasome Inhibitors for Neuroinflammatory Conditions
Time: 1:30 pm
day: Day 2
Details:
- Addressing optimization challenges for achieving brain exposure
- Illustrating the journey to efficacy in mouse models of human disease and validating target engagement in the central nervous system
